SHETZLINE MICHAEL (CMO, SVP & Head of Drug Devt.) received a stock award from IRONWOOD PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/12/2026ACC: 0001193125-26-104111
Officer· CMO, SVP & Head of Drug Devt.
Since Apr 2020
+136.61K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
136.61K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+136.61K
Price / share
—
Trade value
—
% of position
26.2%
3/10/2026
521.42K→658.04K
Total
Net shares
+136.61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/10/2026 | A · Award | +136.61K | — | — | 26.2% | 521.42K | 658.04K |
| Total | +136.61K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported